Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591537 · ClinicalTrials.gov registry record · NA
OxyGenesys Dissolved Oxygen Dressing; Abdominoplasty at Northwestern University
A NA study, sponsored by Halyard Health.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02591537 is a NA study that has completed, run by Halyard Health. The registered enrollment target is 8 participants.
The verdict
NCT02591537, a NA study, has completed, sponsored by Halyard Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Twelve acute wounds (6 on either side of the umbilicus) will be surgically created in the lower abdominal area. One side of the umbilicus will be randomized to Oxygenesys treatment arm and the other side will be receiving a standard Tegaderm treatment arm. Time to wound healing will be observed over 14 days.
Interventions
- DEVICE OxyGenesys Dissolved Oxygen Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02591537
The ClinicalTrials.gov registry entry for NCT02591537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Halyard Health, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OxyGenesys Dissolved Oxygen Dressing is the first listed.
NCT02591537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02591537 about?
NCT02591537 is a clinical study titled "OxyGenesys Dissolved Oxygen Dressing; Abdominoplasty at Northwestern University". Twelve acute wounds (6 on either side of the umbilicus) will be surgically created in the lower abdominal area. One side of the umbilicus will be randomized to Oxygenesys treatment arm and the other side will be receiving a standard Tegaderm treatment arm. Time to wound healing will be observed over...
What is the current status of trial NCT02591537?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-10. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02591537?
The interventions under investigation include: OxyGenesys Dissolved Oxygen Dressing (DEVICE).
Who is sponsoring clinical trial NCT02591537?
This trial is sponsored by Halyard Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.